RTX toxin enhances the survival of Vibrio vulnificus during infection by protecting the organism from phagocytosis

Journal of Infectious Diseases

Volumn 203, Issue 12, 2011, Pages 1866-1874

  Lo, Horng Ren ^a,c   Lin, Jen Hsing ^a   Chen, Yi Hsuan ^a   Chen, Chun Liang ^a   Shao, Chung Ping ^b   Lai, Yi Chi ^d   Hor, Lien I ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL TAINAN INSTITUTE OF NURSING   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOTOXIN; REPEATS IN TOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL TRANSLOCATION; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOTOXICITY; MOUSE; NEUTROPENIA; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; TOXIN ANALYSIS; VIBRIO VULNIFICUS; VIBRIO VULNIFICUS INFECTION;

ANIMALS; BACTERIAL TOXINS; CELL LINE; CYTOTOXINS; HUMANS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MUTATION; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; VIBRIO INFECTIONS; VIBRIO VULNIFICUS; VIRULENCE;

EID: 79957460190     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir070     Document Type: Article

References (37)

1. Tacket CO, Brenner F, Blake PA. Clinical features and an epidemiological study of Vibrio vulnificus infections. J Infect Dis 1984; 149:558-61. (Pubitemid 14139040)
2. Oliver JD. Wound infections caused by Vibrio vulnificus and other marine bacteria. Epidemiol Infect 2005; 133:383-91. (Pubitemid 40867674)
3. Oliver JD, Wear JE, Thomas MB, Warner M, Linder K. Production of extracellular enzymes and cytotoxicity by Vibrio vulnificus. Diagn Microbiol Infect Dis 1986; 5:99-111. (Pubitemid 16091103)
4. Gray LD, Kreger AS. Mouse skin damage caused by cytolysin from Vibrio vulnificus and by V. vulnificus infection. J Infect Dis 1987; 155:236-41. (Pubitemid 17022863)
5. Kothary MH, Kreger AS. Purification and characterization of an elastolytic protease of Vibrio vulnificus. J Gen Microbiol 1987; 133:1783-91. (Pubitemid 17140464)
6. Miyoshi S, Nakazawa H, Kawata K, Tomochika K, Tobe K, Shinoda S. Characterization of the hemorrhagic reaction caused by Vibrio vulnificus metalloprotease, a member of the thermolysin family. Infect Immun 1998; 66:4851-5. (Pubitemid 28453092)
7. Wright AC, Morris JG Jr. The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice. Infect Immun 1991; 59:192-7.
8. Jeong KC, Jeong HS, Rhee JH, et al. Construction and phenotypic evaluation of a Vibrio vulnificus vvpE mutant for elastolytic protease. Infect Immun 2000; 68:5096-106.
9. Shao CP, Hor LI. Metalloprotease is not essential for Vibrio vulnificus virulence in mice. Infect Immun 2000; 68:3569-73.
10. Fan JJ, Shao CP, Ho YC, Yu CK, Hor LI. Isolation and characterization of a Vibrio vulnificus mutant deficient in both extracellular metalloprotease and cytolysin. Infect Immun 2001; 69:5943-8.
11. Liu M, Alice AF, Naka H, Crosa JH. The HlyU protein is a positive regulator of rtxA1, a gene responsible for cytotoxicity and virulence in the human pathogen Vibrio vulnificus. Infect Immun 2007; 75:3282-9. (Pubitemid 47040929)
12. Kim YR, Lee SE, Kook H, et al. Vibrio vulnificus RTX toxin kills host cells only after contact of the bacteria with host cells. Cell Microbiol 2008; 10:848-62. (Pubitemid 351386941)
13. Lee JH, Kim MW, Kim BS, et al. Identification and characterization of the Vibrio vulnificus rtxA essential for cytotoxicity in vitro and virulence in mice. J Microbiol 2007; 45:146-52.
14. Lally ET, Hill RB, Kieba IR, Korostoff J. The interaction between RTX toxins and target cells. Trends Microbiol 1999; 7:356-61. (Pubitemid 29421660)
15. Menestrina G, Moser C, Pellet S, Welch R. Pore-formation by 475 Escherichia coli hemolysin (HlyA) and other members of the RTX toxins family. Toxicology 1994; 87:249-67. (Pubitemid 24097464)
16. Clarke CR, Confer AW, Mosier DA. In vivo effect of Pasteurella haemolytica infection on bovine neutrophil morphology. Am J Vet Res 1998; 59:588-92.
17. Fong KP, Pacheco CM, Otis LL, et al. Actinobacillus actinomycetemcomitans leukotoxin requires lipid microdomains for target cell cytotoxicity. Cell Microbiol 2006; 8:1753-67. (Pubitemid 44530668)
18. Bauche C, Chenal A, Knapp O, et al. Structural and functional characterization of an essential RTX subdomain of Bordetella pertussis adenylate cyclase toxin. J Biol Chem 2006; 281:16914-26.
19. Welch RA, Forestier C, Lobo A, Pellett S, Thomas W Jr., Rowe G. The synthesis and function of the Escherichia coli hemolysin and related RTX exotoxins. FEMS Microbiol Immunol 1992; 5:29-36.
20. Lin W, Fullner KJ, Clayton R, et al. Identification of a Vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. Proc Natl Acad Sci U S A 1999; 96:1071-6. (Pubitemid 29072185)
21. Fullner KJ, Mekalanos JJ. In vivo covalent cross-linking of cellular actin by the Vibrio cholerae RTX toxin. EMBO J 2000; 19:5315-23.
22. Cordero CL, Kudryashov DS, Reisler E, Satchell KJ. The Actin cross-linking domain of the Vibrio cholerae RTX toxin directly catalyzes the covalent cross-linking of actin. J Biol Chem 2006; 281:32366-74. (Pubitemid 46036791)
23. Sheahan KL, Satchell KJ. Inactivation of small Rho GTPases by the multifunctional RTX toxin from Vibrio cholerae. Cell Microbiol 2007; 9:1324-35. (Pubitemid 46547147)
24. Chung KJ, Cho EJ, Kim MK, et al. RtxA1-induced expression of the small GTPase Rac2 plays a key role in the pathogenicity of Vibrio vulnificus. J Infect Dis 2010; 201:97-105.
25. Donnenberg MS, Kaper JB. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun 1991; 59:4310-7.
26. Sun J, Ramnath RD, Bhatia M. Neuropeptide substance P upregulates chemokine and chemokine receptor expression in primary mouse neutrophils. Am J Physiol Cell Physiol 2007; 293:C696-704.
27. Reed LJ, Muench H. A simple method of estimating the fifty percent endpoints. Am J Hyg 1938; 27:493-7.
28. Kuo CF, Wu JJ, Lin KY, et al. Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect Immun 1998; 66:3931-5.
29. Van Dyk TK, Rosson RA. Photorhabdus luminescens luxCDABE promoter probe vectors. Methods Mol Biol 1998; 102:85-95.
30. Johnson DE, Calia FM. Hemolytic reaction of clinical and environmental strains of Vibrio vulnificus. J Clin Microbiol 1981; 14:457-9. (Pubitemid 11007014)
31. Tsuchiya T, Mitsuo E, Hayashi N, et al. Vibrio vulnificus damages macrophages during the early phase of infection. Infect Immun 2007; 75:4592-6.
32. Strom MS, Paranjpye RN. Epidemiology and pathogenesis of Vibrio vulnificus. Microbes Infect 2000; 2:177-88.
33. Jones MK, Oliver JD. Vibrio vulnificus: disease and pathogenesis. Infect Immun 2009; 77:1723-33.
34. Bokoch GM. Regulation of innate immunity by Rho GTPases. Trends Cell Biol 2005; 15:163-71. (Pubitemid 40332539)
35. Hoppe AD, Swanson JA. Cdc42, Rac1, and Rac2 display distinct patterns of activation during phagocytosis. Mol Biol Cell 2004; 15:3509-19.
36. 125I-labelled HSA-antibody complexes by these cells. Immunology 1975; 28:59-70.
37. Fullner KJ, Boucher JC, Hanes MA, et al. The contribution of accessory toxins of Vibrio cholerae O1 El Tor to the proinflammatory response in a murine pulmonary cholera model. J Exp Med 2002; 195:1455-62.